Leslie is currently the MD/CEO of Imugene developing immunooncology therapy. She has more than 21 years of experience in leading clinical and department development in cancer therapy. She has therapeutic expertise in all areas of oncology indication but with special focus and dedication to finding a cure for brain cancer. Leslie believes that early development and research in oncology innovations has the ability
to bring transformative medicine to cancer patients.
Click here for the audio only version of this podcast
Join our closed Facebook support group